FEATURED COMPANIES
- 3M Inc
- ConvaTec Group
- Kerecis
- Mallinckrodt
- Medtronic
- Molnlycke Health Care
The Global Tissue Engineered Skin Substitutes Market is estimated to be USD 703.3 Mn in 2021 and is expected to reach USD 864 Mn by 2026, growing at a CAGR of 4.2%.
Market Dynamics
Key factors, such as increasing prevalence of acute and chronic wounds, growing burn & trauma cases, rising demand for skin grafts, and rising focus on technological advancements have led to a rise in tissue engineered skin substitutes market. Increase in number of patients suffering from diabetic and vascular ulcers is also driving the need for tissue engineering. Rising awareness regarding various treatment options, ability of tissue engineering to replace conventional auto - and allografts is also fuelling the demand for tissue engineered skin substitutes.
However, the factor such as lack of proper reimbursement policies, high treatment cost and prolonged duration required for treatment is hindering the market growth. Issues with biomaterials used for skin grafts, such as biomaterial-centred infection and poor tissue integration may be challenging for the growth of the market.
Market Segmentation
The Global Tissue Engineered Skin Substitutes Market is segmented further based on Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End User, and Geography.
By Biomaterial, the market is classified as autologous, allogeneic, xenogeneic and amnion. Amongst the two, the Autologous segment is estimated to hold the highest market share.
By Anatomical Structure, the market is segmented as Cellular and Acellular. Acellular Anatomical Structure is estimated to hold the highest market share during the forecast period.
By Product Type, the market is classified as Natural and Synthetic. Synthetic products are further segmented as biodegradable and Non-biodegradable. Natural segment holds the highest market share.
By Application, the market is classified as chronic wounds, burns cases, traumatic wounds, diabetic foot ulcers and others. Amongst all, the Chronic Wounds segment is estimated to hold the highest market share.
By Technology, the market is classified as Laser assisted bio-printing, 3D, Robotic Technology, and Others. Amongst them, the 3D Technology is estimated to hold the highest market share.
By Duration, the market is classified as Permanent and Semi-permanent. Amongst the two, the Permanent segment is estimated to hold the highest market share.
By End User, the market is classified as Hospital and Clinic, Ambulatory Surgical Center, and Others. The Hospital and Clinic segment is estimated to hold the highest market share.
By Geography, North America dominates the market.
Recent Developments
1. Acelity enters agreement to transition Systagenix manufacturing facility to Scapa Healthcare. - September 2020
2. Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc. - December 2020
Company Profiles
Some of the companies covered in this report Smith & Nephew, Mölnlycke Health Care, Integra LifeSciences, Regenicin., Organogenesis Inc, MiMedx., LifeNet Health, Kerecis, Medline Industries, BSN medical, ConvaTec Group, Mallinckrodt, Tissue Regenix, etc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
Key factors, such as increasing prevalence of acute and chronic wounds, growing burn & trauma cases, rising demand for skin grafts, and rising focus on technological advancements have led to a rise in tissue engineered skin substitutes market. Increase in number of patients suffering from diabetic and vascular ulcers is also driving the need for tissue engineering. Rising awareness regarding various treatment options, ability of tissue engineering to replace conventional auto - and allografts is also fuelling the demand for tissue engineered skin substitutes.
However, the factor such as lack of proper reimbursement policies, high treatment cost and prolonged duration required for treatment is hindering the market growth. Issues with biomaterials used for skin grafts, such as biomaterial-centred infection and poor tissue integration may be challenging for the growth of the market.
Market Segmentation
The Global Tissue Engineered Skin Substitutes Market is segmented further based on Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End User, and Geography.
By Biomaterial, the market is classified as autologous, allogeneic, xenogeneic and amnion. Amongst the two, the Autologous segment is estimated to hold the highest market share.
By Anatomical Structure, the market is segmented as Cellular and Acellular. Acellular Anatomical Structure is estimated to hold the highest market share during the forecast period.
By Product Type, the market is classified as Natural and Synthetic. Synthetic products are further segmented as biodegradable and Non-biodegradable. Natural segment holds the highest market share.
By Application, the market is classified as chronic wounds, burns cases, traumatic wounds, diabetic foot ulcers and others. Amongst all, the Chronic Wounds segment is estimated to hold the highest market share.
By Technology, the market is classified as Laser assisted bio-printing, 3D, Robotic Technology, and Others. Amongst them, the 3D Technology is estimated to hold the highest market share.
By Duration, the market is classified as Permanent and Semi-permanent. Amongst the two, the Permanent segment is estimated to hold the highest market share.
By End User, the market is classified as Hospital and Clinic, Ambulatory Surgical Center, and Others. The Hospital and Clinic segment is estimated to hold the highest market share.
By Geography, North America dominates the market.
Recent Developments
1. Acelity enters agreement to transition Systagenix manufacturing facility to Scapa Healthcare. - September 2020
2. Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc. - December 2020
Company Profiles
Some of the companies covered in this report Smith & Nephew, Mölnlycke Health Care, Integra LifeSciences, Regenicin., Organogenesis Inc, MiMedx., LifeNet Health, Kerecis, Medline Industries, BSN medical, ConvaTec Group, Mallinckrodt, Tissue Regenix, etc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Tissue Engineered Skin Substitutes Market.
- The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
- The report also contains the competitive analysis using Competitive Quadrant, the analyst's proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Tissue Engineered Skin Substitutes Market
What is the estimated value of the Global Tissue Engineered Skin Substitutes Market?
What is the growth rate of the Global Tissue Engineered Skin Substitutes Market?
What is the forecasted size of the Global Tissue Engineered Skin Substitutes Market?
Who are the key companies in the Global Tissue Engineered Skin Substitutes Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- 3M Inc
- ConvaTec Group
- Kerecis
- Mallinckrodt
- Medtronic
- Molnlycke Health Care
1 Report Description
2 Research Methodology
4 Market Overview
5 Market Analysis
6 Global Tissue Engineered Skin Substitutes Market, By Biomaterial
7 Global Tissue Engineered Skin Substitutes Market, By Anatomical Structure
8 Global Tissue Engineered Skin Substitutes Market, By Product Type
9 Global Tissue Engineered Skin Substitutes Market, By Application
10 Global Tissue Engineered Skin Substitutes Market, By Technology
11 Global Tissue Engineered Skin Substitutes Market, By Duration
12 Global Tissue Engineered Skin Substitutes Market, By End User
13 Global Tissue Engineered Skin Substitutes Market, By Geography
14 Competitive Landscape
15 Company Profiles
16 Appendix
Note: Product cover images may vary from those shown
- Organogenesis, Inc
- Smith & Nephew
- BSN Medical
- Molnlycke Health Care
- Integra LifeSciences
- Medtronic
- Tissue Regenix Ltd
- Stratatech (A Mallinckrodt Company)
- Regenicin
- MiMedx
- LifeNet Health
- Kerecis
- Medline Industries, Inc
- ConvaTec Group
- Mallinckrodt
- Amarantus Bioscience Holdings
- 3M Inc
Note: Product cover images may vary from those shown